{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:12:30Z","timestamp":1794755550392,"version":"4.9.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2021RIS-001"],"award-info":[{"award-number":["2021RIS-001"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020172","name":"San Diego Digestive Diseases Research Center, School of Medicine, University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A5A2015541"],"award-info":[{"award-number":["2017R1A5A2015541"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C1090178"],"award-info":[{"award-number":["2019R1A2C1090178"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.metabol.2024.156114","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T23:54:16Z","timestamp":1735257256000},"page":"156114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A3AR antagonism mitigates metabolic dysfunction-associated steatotic liver disease by exploiting monocyte-derived Kupffer cell necroptosis and inflammation resolution"],"prefix":"10.1016","volume":"164","author":[{"given":"Jeong-Su","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyan","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nodir","family":"Rustamov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyeong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Woong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Bae","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Tae","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lak Shin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Seok","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2024.156114_bb0005","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156114_bb0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156114_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2024.156114_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155663","article-title":"Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD","volume":"147","author":"Fernandez-Saez","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156114_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155380","article-title":"Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R\/EGR1\/PDGF-BB signaling pathway","volume":"140","author":"Wang","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156114_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156114_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155272","article-title":"CX3CL1\/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1\/M2 status","volume":"136","author":"Ni","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156114_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.metabol.2024.156114_bb0045","doi-asserted-by":"crossref","unstructured":"Park SJ, Garcia Diaz J, Um E, Hahn YS. Major roles of kupffer cells and macrophages in NAFLD development. Front Endocrinol (Lausanne) 2023;14:1150118.","DOI":"10.3389\/fendo.2023.1150118"},{"key":"10.1016\/j.metabol.2024.156114_bb0050","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jcmgh.2023.02.010","article-title":"Hepatic stellate cells: dictating outcome in nonalcoholic fatty liver disease","volume":"15","author":"Wiering","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2101\u201316","key":"10.1016\/j.metabol.2024.156114_bb0055","article-title":"A subset of Kupffer cells regulates metabolism through the expression of CD36","volume":"54","author":"Bleriot","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2024.156114_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113164","article-title":"Monocyte-derived Kupffer cells dominate in the Kupffer cell pool during liver injury","volume":"42","author":"Li","year":"2023","journal-title":"Cell Rep"},{"issue":"627\u201340","key":"10.1016\/j.metabol.2024.156114_bb0065","article-title":"Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis","volume":"53","author":"Tran","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2024.156114_bb0070","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41423-020-00606-3","article-title":"Monocyte-derived KCs (MoKCs) contribute to the KC pool in NASH","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.metabol.2024.156114_bb0075","first-page":"1208","article-title":"Selective depletion of hepatic Kupffer cells significantly alleviated hepatosteatosis and intrahepatic inflammation induced by high fat diet","volume":"59","author":"Chen","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.metabol.2024.156114_bb0080","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.it.2020.07.001","article-title":"To kill a microglia: a case for CSF1R inhibitors","volume":"41","author":"Green","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.metabol.2024.156114_bb0085","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fphar.2019.00306","article-title":"Macrophage death as a pharmacological target in atherosclerosis","volume":"10","author":"Martinet","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2024.156114_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","article-title":"Adenosine receptors as therapeutic targets","volume":"5","author":"Jacobson","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.metabol.2024.156114_bb0095","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2024.156114_bb0100","doi-asserted-by":"crossref","unstructured":"Stemmer SM, Manojlovic NS, Marinca MV, Petrov P, Cherciu N, Ganea D, et al. Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13020187"},{"key":"10.1016\/j.metabol.2024.156114_bb0105","first-page":"199","article-title":"cAMP and mitochondria","volume":"28","author":"Valsecchi","year":"2013","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.metabol.2024.156114_bb0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13059-017-1220-4","article-title":"Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins","volume":"18","author":"Quadros","year":"2017","journal-title":"Genome Biol"},{"key":"10.1016\/j.metabol.2024.156114_bb0115","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition","volume":"301","author":"Charlton","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2024.156114_bb0120","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"Machado","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2024.156114_bb0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.metabol.2024.156114_bb0130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.metabol.2024.156114_bb0135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2024.156114_bb0140","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41419-022-05395-3","article-title":"Tubular beta-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2024.156114_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.14336\/AD.2021.0729","article-title":"Mammalian AKT, the emerging roles on mitochondrial function in diseases","volume":"13","author":"Xie","year":"2022","journal-title":"Aging Dis"},{"key":"10.1016\/j.metabol.2024.156114_bb0150","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1021\/jm070259t","article-title":"Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4\u2032-thioadenosine derivatives without 4\u2032-hydroxymethyl group as highly potent and selective antagonists","volume":"50","author":"Jeong","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2024.156114_bb0155","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.tips.2011.05.002","article-title":"beta-Arrestin-mediated receptor trafficking and signal transduction","volume":"32","author":"Shenoy","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2024.156114_bb0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-642-41199-1_9","article-title":"beta-arrestins and G protein-coupled receptor trafficking","volume":"219","author":"Tian","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.metabol.2024.156114_bb0165","series-title":"Wang X","first-page":"220","author":"Yang","year":"2021"},{"key":"10.1016\/j.metabol.2024.156114_bb0170","doi-asserted-by":"crossref","unstructured":"Martys JL, Wjasow C, Gangi DM, Kielian MC, McGraw TE, Backer JM. Wortmannin-sensitive trafficking pathways in Chinese hamster ovary cells. Differential effects on endocytosis and lysosomal sorting. J Biol Chem 1996;271:10953\u201362.","DOI":"10.1074\/jbc.271.18.10953"},{"key":"10.1016\/j.metabol.2024.156114_bb0175","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fimmu.2016.00597","article-title":"ATP-induced Inflammasome activation and Pyroptosis is regulated by AMP-activated protein kinase in macrophages","volume":"7","author":"Zha","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2024.156114_bb0180","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.metabol.2024.156114_bb0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.metabol.2024.156114_bb0190","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s12276-023-01046-5","article-title":"Mitochondria-associated programmed cell death as a therapeutic target for age-related disease","volume":"55","author":"Nguyen","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.metabol.2024.156114_bb0195","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","article-title":"Mitochondria and cell death","volume":"26","author":"Glover","year":"2024","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2024.156114_bb0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s44321-023-00011-z","article-title":"Mediators of necroptosis: from cell death to metabolic regulation","volume":"16","author":"Wu","year":"2024","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.metabol.2024.156114_bb0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12964-024-01804-6","article-title":"Targeting necroptosis: a promising avenue for respiratory disease treatment","volume":"22","author":"Cao","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.metabol.2024.156114_bb0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fimmu.2016.00123","article-title":"The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases","volume":"7","author":"Raker","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2024.156114_bb0215","first-page":"995","article-title":"Adenosine signaling in tumor-associated macrophages and targeting adenosine signaling for cancer therapy","volume":"21","author":"Yang","year":"2024","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.metabol.2024.156114_bb0220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.metabol.2024.156114_bb0225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41388-021-02090-z","article-title":"Cancer biology and molecular genetics of a(3) adenosine receptor","volume":"41","author":"Mazziotta","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.metabol.2024.156114_bb0230","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway","volume":"29","author":"Canas","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2024.156114_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112482","article-title":"Down-regulation of a(3)AR signaling by IL-6-induced GRK2 activation contributes to Th17 cell differentiation","volume":"399","author":"Hu","year":"2021","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.metabol.2024.156114_bb0240","first-page":"2256","article-title":"The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice","volume":"44","author":"Fishman","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.metabol.2024.156114_bb0245","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0028-3908(97)00104-4","article-title":"Pharmacological characterization of novel A3 adenosine receptor-selective antagonists","volume":"36","author":"Jacobson","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.metabol.2024.156114_bb0250","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1124\/jpet.103.057083","article-title":"Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation","volume":"308","author":"Vortherms","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.metabol.2024.156114_bb0255","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","article-title":"Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis","volume":"44","author":"Tong","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.metabol.2024.156114_bb0260","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.clnu.2024.08.007","article-title":"FNDC4 reduces hepatocyte inflammatory cell death via AMPKalpha in metabolic dysfunction-associated steatotic liver disease","volume":"43","author":"Neira","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.metabol.2024.156114_bb0265","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.7150\/ijbs.92371","article-title":"A novel A2a adenosine receptor inhibitor effectively mitigates hepatic fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model","volume":"20","author":"Park","year":"2024","journal-title":"Int J Biol Sci"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524003421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524003421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T04:45:40Z","timestamp":1738298740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524003421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":53,"alternative-id":["S0026049524003421"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156114","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A3AR antagonism mitigates metabolic dysfunction-associated steatotic liver disease by exploiting monocyte-derived Kupffer cell necroptosis and inflammation resolution","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156114"}}